# A Study to Assess the Food Effect on Bioavailability of Metformin/Gliclazide in Healthy Participants

> **NCT03467971** · PHASE1 · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 21 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Metformin/Gliclazide Fixed Combination

## Key facts

- **NCT ID:** NCT03467971
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-06
- **Primary completion:** 2018-04-22
- **Final completion:** 2018-04-22
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2019-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03467971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03467971, "A Study to Assess the Food Effect on Bioavailability of Metformin/Gliclazide in Healthy Participants". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03467971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*